CNBC Utilities Page Drugs


  • Obama: US Zika cases appear to be travel-related

    CNBC's Eamon Javers reports on President Obama's comments after a briefing on the Zika virus.

  • Sarepta awaits drug approval

    CNBC's Meg Tirrell talks about whether the FDA will approve Sarepta's Muscular Dystrophy drug and what could happen to the company's stock. The "FMHR" traders debate the trade.

  • Elizabeth Holmes, founder and CEO of Theranos.

    Blood-testing startup Theranos posted a job opening Thursday looking for an executive assistant to CEO Elizabeth Holmes.

  • Targeting cancer

    Robert Mulroy, Merrimack Pharmaceuticals CEO, discusses the company's oncology pipeline and clinical basket trial.

  • Heart attack gene?

    Amgen is working on a drug to lower the risk of heart attack, reports CNBC's Meg Tirrell.

  • Russian tennis chief says Maria Sharapova may never play again

    The tennis star tested positive for a banned drug at the Australian Open in January.

  • NEW YORK, May 19- Health insurer Cigna Corp plans to cut its customers' prescriptions for opioid treatments by 25 percent over the next three years, putting its weight behind a U.S. government battle against addictive painkillers. President Barack Obama earlier this year asked Congress for $1.1 billion in new funding over two years to expand treatment for a...

  • BOGOTA, Colombia— Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals. Memos leaked last week to a nonprofit group, written from the Colombian Embassy in Washington, describe intense lobbying...

  • DOJ opens investigation into Russian doping scandal -NYT

    CNBC's Eamon Javers reports on the Department of Justice opening an investigation into the Russian doping scandal, according to the New York Times.

  • May 17- Walgreens Boots Alliance Inc. is making the opioid antidote naloxone available without a prescription in all its pharmacies in New Mexico, part of a plan to make the drug readily available in 35 states by the end of this year. The drugstore chain has already made naloxone available without a prescription in Alabama, Indiana, Massachusetts, New Jersey, New...

  • Citron to Mallinckrodt: Test your drug!

    Citron Research's executive editor Andrew Left is long Valeant, short Mallinckrodt Pharmaceuticals.

  • Biggest seizure of drugs in history

    More than eight tons of cocaine were seized in Colombia, reports CNBC's Michelle Caruso-Cabrera.

  • Pfizer blocks use of its drugs in executions: NYT

    CNBC's Sue Herera provides insight to a report regarding drugs used in lethal injections.

  • Falls upends

    Shares of Valeant fell nearly 6 percent after the New York Times reported the company has not kept the discount promises it made to Congress.

  • Yet the measures are leaving anti-drug advocates underwhelmed, and Congress won't decide till later how much money it's willing to provide. Frank Guinta of New Hampshire and Bob Dold of Illinois and Sen. Rob Portman, R- Ohio, chief sponsor of similar Senate legislation.

  • Valeant: Broken promises?

    CNBC's Meg Tirrell reports on Valeant possibly not living up to its promise to offer discounts on some drugs.

  • Analyst on Valeant: Scrutiny will only get worse

    David Amsellem of Piper Jaffray discusses a report that hospitals are still waiting on Valeant's promised drug discounts.

  • Report: 15 Russian Olympic champs in doping program

    A New York Times report saying at least 15 Russian gold medal winners from the last winter Olympics in Russia were part of a state-run doping program.

  • Is Uber the new side hustle?

    Technology changes things we wouldn't expect, explains Vanity Fair special correspondent Nick Bilton, after he rode in an Uber where the driver told him about transporting a drug dealer.

  • Genetic Test analytical testing in laboratory

    A new gene test claims it can slow the US painkiller addiction epidemic by identifying likely addicts before a doctor writes a prescription.